Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baimai is a traditional Tibetan medicine (TTM) formulation, most commonly utilized as a topical ointment (Baimai ointment). It is specifically indicated for the treatment of "Baimai" diseases, a category in Tibetan medicine that encompasses disorders of the nervous and musculoskeletal systems, such as paralysis, nerve damage, muscle contractures, and joint stiffness. The formulation is a complex mixture of botanical and mineral ingredients, typically including artificial musk, frankincense, myrrh, turmeric, and other herbs. In modern clinical practice, it is frequently applied to treat conditions such as postherpetic neuralgia, shoulder periarthritis, and cervical spondylosis. Recent clinical research has explored its use as a medicinal coupling agent for extracorporeal shockwave therapy (ESWT) to enhance analgesic and anti-inflammatory outcomes through improved local microcirculation and modulation of pain signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Baimai.